CNTA

Centessa Pharmaceuticals

44 hedge funds and large institutions have $233M invested in Centessa Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

less ownership

Funds ownership:

22% less capital invested

Capital invested by funds: $300M → $233M (-$67.3M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $3K

Holders
44
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
$3K
Net Calls
Net Calls Change

Top Buyers

1 +$6.19M
2 +$5.82M
3 +$1.62M
4
Morgan Stanley
Morgan Stanley
New York
+$926K
5
AAA
Affinity Asset Advisors
New York
+$675K

Top Sellers

1 -$11.7M
2 -$4.37M
3 -$1.61M
4
Citadel Advisors
Citadel Advisors
Florida
-$474K
5
AA
ALPS Advisors
Colorado
-$207K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$61.9M
2
$38.8M
3
$30M
4
$21.4M
5
$16.2M
6
$12.2M
7
$9.11M
8
$7.4M
9
$6.58M
10
$5.82M
11
$5.25M
12
$3.82M
13
$2.58M
14
$2.28M
15
$1.74M
16
$1.59M
17
$1.43M
18
$977K
19
$961K
20
$770K
21
$680K
22
$341K
23
$254K
24
$247K
25
$224K